featured
The Exosome-Based ExoDx Prostate (IntelliScore) EPI Test in Men Presenting for Initial Biopsy With a PSA 2–10 ng/mL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prostate Cancer and Prostatic Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Utility of the Exosome-Based ExoDx Prostate (IntelliScore) EPI Test in Men Presenting for Initial Biopsy With a PSA 2–10 ng/mL
Prostate Cancer Prostatic Dis. 2020 May 07;[EPub Ahead of Print], R Tutrone, MJ Donovan, P Torkler, V Tadigotla, T McLain, M Noerholm, J Skog, J McKiernanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.